There is no need to panic at the need for an immediate change in the Covishield dosage interval: Government | India News

There is no need to panic at the need for an immediate change in the Covishield dosage interval: Government |  India News

NEW DELHI: The government said Friday that there is no need to panic over the need for an immediate change in the dosing interval from Covishield vaccine, stressing that closing the time gap requires proper scientific study in the Indian setting.
In the context of some media reports citing recent studies that it would be better to bridge the gap between two doses of the Covishield vaccine, in light of the variants in circulation, Dr. VK Paul, member (Health) in NITI AayogHe said it is necessary to balance those concerns.
In a press conference on Covid-19, he said: “There is no need to panic, which suggests the need for an immediate change or a change in the gap between doses. All these decisions must be made very carefully. We must Remember that when the gap widened, we had to consider the risk posed by the virus to those who have received a single dose, but the counterpoint was that more people will be able to receive the first dose, thus giving a reasonable degree of immunity to more people. ”
“We need to balance these concerns. Therefore, remember that we necessarily need to have this debate and this speech in the public domain; however, the decision must be made by appropriate forums that include eminent people who are informed about this,” he said. saying.
Paul said at the National Technical Advisory Group on Immunization (NTAGI), there are quite a few people who have served on WHO panels and committees and are globally recognized and recognized for their eminence. It’s more, NTAGI it is considered a standard for national and global immunization programs.
“Therefore, respect their decisions,” he said.
Welcoming a speech on this topic, Paul highlighted the need for scientific due process in reaching such decisions.
He called on the public to respect the decision made by NTAGI, a world-renowned body of experts.
Let the decision on the dose interval be reviewed by NTAGI, according to due process. The UK must have adopted due process and examined the data scientifically to revise its earlier decision regarding the gap. The UK had previously maintained the gap at 12 weeks, but based on the data available to us, we did not consider it safe at the time, he said.
“So, let’s entrust this to our scientific forums, they should already be addressing the issue. They will review it based on the pandemic situation in our country, depending on the degree of prevalence of the delta variant in our country and then they will take a comprehensive analysis. Whatever whatever decision our scientific community makes, we will respect it, “said Paul.


Source link